Kenneth Zuerblis

Mr. Kenneth J.
Zuerblis, CPA, is an Independent Director at Zenith Capital Corp.
(Alberta) and an Independent Director at Resverlogix Corp.
He is on the Board of Directors at Lirum Therapeutics, Inc., Zenith Capital Corp.
(Alberta) and Resverlogix Corp.
Mr. Zuerblis was previously employed as a Chief Financial Officer, Treasurer & Executive VP by Savient Pharmaceuticals, Inc., an Independent Director by Immunomedics, Inc., a Chief Financial Officer & Senior Vice President by ImClone Systems, Inc., a Chief Financial Officer by Enzon Pharmaceuticals, Inc., and a Controller by KPMG LLP.
He also served on the board at Stemline Therapeutics, Inc., XTL Biopharmaceuticals Ltd. and New Jersey Technology Council.
He received his undergraduate degree from Seton Hall University.